Mr. Marc Edwards reports
KANE BIOTECH TO RELEASE THIRD QUARTER 2023 FINANCIAL RESULTS ON NOVEMBER 28, 2023 -– CONFERENCE CALL TO FOLLOW
Kane Biotech Inc. will release its third quarter 2023 financial results after market close on Tuesday, Nov. 28, 2023.
Kane Biotech management will host a conference call at 4:30 p.m. ET to review the financial results and discuss business developments in the period.
Participants must register for the call. It is recommended that you join 10 minutes before the event, though you may preregister at any time. A webcast of the call will be available on the company's website.
About Kane Biotech Inc.
Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The company has a portfolio of biotechnologies, intellectual property (80 patents and patents pending, trade secrets and trademarks) and products developed by the company's own biofilm research expertise and acquired from leading research institutions.
We seek Safe Harbor.
© 2024 Canjex Publishing Ltd. All rights reserved.